TATE and KN046 in MCRC

Clinical trial NCT06834399 · TERMINATED

Trial details

NCT number: NCT06834399
Sponsor: Zhejiang Raygene Pharmaceuticals Co., Ltd
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer with Hepatic Metastases

Start date: 2023-04-27
Primary completion: 2024-12-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.